Black men are at higher risk of being diagnosed with prostate cancer vs. white men, and, once diagnosed, in the U.S. they are more than twice as likely to die of the disease. That worrisome trend is heading in the wrong direction, according to a new editorial in The ASCO Post authored by PCF Chief Medical Officer William K. Oh, MD, and CEO Charles J. Ryan, MD.
In this exclusive interview, Drs. Ryan and Oh explore the multifactorial causes of this disparity and propose potential solutions. Analogous to getting a product into the hands of the consumer, there are complex steps to delivering known best practices in health care over the “last mile” to patients.
Watch the video to learn more, and read the full article here.